Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Cor Therapeutics presents cromafiban, the first orally active once-daily gpIIb/IIIa antagonist

March 11, 1999

ACC highlights: ASSENT 2 study supports improved efficacy of TNK-tPA over t-PA

March 10, 1999

Fragmin found to reduce heart attack and death at 45 days

March 10, 1999

Subanalyses of abciximab trial results presented at ACC meeting

March 10, 1999

Yamanouchi describes novel anticoagulants

March 10, 1999

Hyseq conducts preclinical testing on novel anticoagulant products

March 10, 1999

Corvas presents phase I trial results of novel injectable anticoagulant at ACC meeting

March 9, 1999

Novel hemostatic cofactors available for licensing from OMRF

March 9, 1999

Microbial fatty acid enhances endothelial cell fibrinolytic activity

March 8, 1999

Bio-Technology General receives added patent protection for novel anticoagulant

March 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...